A New Haven drug maker and Hamden research center have been paired in a new, late-stage clinical trial to slow or stop the symptoms of Alzheimer’s disease. Biohaven Pharmaceuticals announced enrolling its first patient in August, and is still seeking more participants for the study, which is being...